GLP-1 Left Out of the Fridge? How Long It's Still Good (2026)
How long semaglutide, tirzepatide and compounded GLP-1s last outside the fridge, per FDA labeling — plus what heat and freezing actually do to a peptide, and when a vial is no longer safe to use.
More on What If Questions
Important Medical Disclaimer
This article is for informational purposes only. When in doubt about medication integrity, contact your pharmacy rather than using potentially degraded medication. Do not use any medication that appears discolored, cloudy, or contains particles.
The Direct Answer
Brief exposure to warmth (a few hours at room temperature) is usually fine. Extended heat exposure above 86F/30C can degrade your medication and make it less effective or potentially unsafe.
Semaglutide and tirzepatide are peptide-based medications that are sensitive to temperature extremes. They should be refrigerated (36-46F / 2-8C) before first use. However, they are more resilient than many people think -- every approved GLP-1 carries a labeled room-temperature allowance measured in weeks, not hours. The exact figure differs by product, and the table below gives each one.
The real danger is sustained high heat: a car dashboard in summer, a mailbox in direct sunlight, or luggage in an airplane cargo hold. These environments can exceed safe temperatures and permanently damage the medication.
How long each GLP-1 lasts outside the fridge
The room-temperature window is set by the manufacturer's stability testing and printed on the approved label, so it differs by product. Per FDA prescribing information:
| Medication | Unopened storage | Room-temperature window |
|---|---|---|
| Semaglutide (Ozempic) | Refrigerate 36-46F until the expiry date | Up to 56 days at 59-86F, counting both before and after first use |
| Semaglutide (Wegovy) | Refrigerate 36-46F until the expiry date | Up to 28 days at 46-86F, prior to cap removal, kept in the original carton |
| Tirzepatide (Mounjaro, Zepbound) | Refrigerate 36-46F until the expiry date | Up to 21 days at or below 86F |
| Compounded semaglutide or tirzepatide | Per the beyond-use date on the pharmacy label | Follow the dispensing pharmacy's written instructions |
That last row matters more than people expect. A compounded preparation carries a beyond-use date assigned by the pharmacy that made it, based on that pharmacy's formulation and testing. It is not the same figure as a brand label's window, and you should not substitute one for the other. If your vial's instructions are missing or unreadable, ask the pharmacy rather than guessing.
One clarification on the counting: the room-temperature window is cumulative, not a fresh allowance each time. An in-use pen that spends four days on a counter and is then returned to the fridge has used four days of its window, not reset it.
Ask a provider, not a search bar
Not sure if your medication is still good? Message a provider.
Trimi memberships include unlimited messaging with licensed providers, so you can ask about heat exposure, storage, or whether a shipment needs review before you inject anything questionable. Clinician-guided compounded semaglutide is $99/mo and tirzepatide is $125/mo on the annual plan, all-inclusive, backed by a 6-month money-back policy. Individual results vary.
Start your online visitTemperature Guidelines
Refrigerated (36-46F / 2-8C) -- Ideal
Best for long-term storage of unopened medication. Keeps medication at maximum potency through expiration date.
Room Temperature (59-86F / 15-30C) -- Acceptable
Fine for an in-use pen or for transport, within your product's labeled allowance -- 21 to 56 days depending on the medication. See the table above for yours.
Above 86F (30C) -- Potentially Harmful
Extended exposure degrades the peptide. If left in high heat for more than a few hours, the medication may lose potency.
Freezing (Below 32F / 0C) -- Do Not Use
Freezing damages the protein structure of GLP-1 medications. If your medication has frozen, discard it even if it has thawed.
Storage Best Practices
At Home
Store unopened pens in the refrigerator (not the freezer compartment). Keep the in-use pen at room temperature or in the fridge -- both are fine.
While Traveling
Use an insulated case with gel packs. Keep in your carry-on (not checked luggage). Never leave in a hot car.
Package Deliveries
Ask for signature-required delivery to avoid prolonged mailbox exposure. Retrieve packages promptly, especially in summer.
Before You Inject: A 5-Second Visual Check
Time and temperature tell you what probably happened. Looking at the solution tells you what actually did. Semaglutide and tirzepatide should be clear and colorless, so haze, visible particles, or a yellow or brown tint mean the peptide has aggregated — molecules clumping together after heat, freezing, or agitation stress.
Aggregated peptide does not deliver a reliable dose, so a hazy vial is not simply a "weaker" one, and protein aggregates are a recognized immunogenicity risk in injectable biologics. That is why manufacturers specify inspection before every dose rather than treating it as optional. If the solution looks wrong, do not inject it — photograph the vial, keep it, and contact your pharmacy, which will usually replace a shipment that arrived compromised.
For the full inspection walkthrough — what each type of discoloration indicates and when a vial is definitely done — see our guide to inspecting a GLP-1 that was left unrefrigerated.
Peptides Without FDA-Approved Labeling
Every storage window on this page — the 56 days, the 28 days, the 21 days — exists because a manufacturer ran stability testing, submitted it to the FDA, and had it reviewed before it was printed on a label. The number is a regulatory output, not a property of peptides in general.
Peptides sold without that approval, including retatrutide and other compounds distributed through research-chemical suppliers, have no reviewed stability data behind them. There is no established room-temperature window to cite because no regulator has evaluated one. Concentration, buffer composition, and purity also vary between suppliers, so a rule borrowed from semaglutide or tirzepatide does not transfer to an unapproved vial — the underlying formulation is different, and in most cases undocumented.
Trimi does not prescribe, compound, or sell retatrutide or any other peptide that lacks FDA approval, and we are not able to advise on storing or handling one. If you have a vial you are unsure about, the safe step is to speak with a licensed clinician before injecting anything.
Frequently Asked Questions
How long can a GLP-1 be out of the fridge?
It depends on the product. Per FDA prescribing information, Ozempic allows up to 56 days at 59-86F counting both before and after first use, Wegovy up to 28 days at 46-86F prior to cap removal in its original carton, and Mounjaro or Zepbound up to 21 days at or below 86F. A compounded semaglutide or tirzepatide vial follows the beyond-use date assigned by the pharmacy that prepared it, which is not the same as a brand label window. The allowance is cumulative -- time spent at room temperature does not reset when the medication goes back in the fridge.
I left my GLP-1 out overnight. Is it ruined?
Usually not. A single overnight stretch at normal indoor room temperature falls inside the labeled room-temperature window for every approved GLP-1, and it counts against that window rather than voiding the medication. The exceptions are heat and freezing: if it sat somewhere that exceeded 86F, such as a closed car, a windowsill in direct sun, or a mailbox on a hot day, or if it was near or below freezing, treat it as suspect. Inspect the solution before using it and contact your pharmacy if anything looks off.
I accidentally froze my GLP-1. Can I still use it?
No. Freezing disrupts the peptide's structure, and the damage is not reversed by thawing -- medication that has frozen should be discarded even if it looks normal afterward. This applies whether it froze in a too-cold refrigerator, against the back wall near the cooling element, or in transit. Contact your pharmacy about a replacement.
What happens if I inject cloudy medication?
Do not inject it. Semaglutide and tirzepatide should be clear and colorless, and cloudiness indicates the peptide has aggregated after heat, freezing, or agitation stress. An aggregated solution will not deliver a reliable dose, and protein aggregates are a recognized immunogenicity risk in injectable biologics. Cloudiness cannot be shaken, warmed, or filtered out. Photograph the vial, keep it, and contact your pharmacy.
What temperature ruins GLP-1 medications?
Temperatures above 86F (30C) can degrade GLP-1 medications. Freezing also damages the medication. Do not use any GLP-1 product that has been frozen or exposed to temperatures above 86F for extended periods. Brief exposure (under 1-2 hours) is usually fine.
How can I tell if my GLP-1 medication has gone bad?
Check for: discoloration (should be clear and colorless), particles or cloudiness in the solution, unusual odor, or changes in consistency. If the medication looks or smells different than when you received it, do not use it. When in doubt, contact your pharmacy.
Can I travel with GLP-1 medications?
Yes. Use an insulated medication travel case with ice packs for trips. Keep medication in your carry-on bag (not checked luggage) when flying. TSA allows injectable medications with proper labeling. Avoid leaving medication in hot cars, and request a mini-fridge at hotels.
What if my medication was delivered and sat in a hot mailbox?
Check the packaging -- most GLP-1 medications are shipped with cold packs. If the cold packs are still cool, the medication is likely fine. If the medication feels warm to the touch and cold packs are fully melted, contact your pharmacy. They may replace the shipment.
Get Properly Shipped GLP-1 Medication Delivered to You
Trimi ships medications with proper cold chain handling. Semaglutide from $99/mo, tirzepatide from $125/mo.
Start your online visitSources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information, Ozempic (semaglutide) injection — Section 16, Storage and Handling.
- FDA Prescribing Information, Wegovy (semaglutide) injection — Section 16, Storage and Handling.
- FDA Prescribing Information, Mounjaro (tirzepatide) injection — Section 16, Storage and Handling.
- FDA Prescribing Information, Zepbound (tirzepatide) injection — Section 16, Storage and Handling.
- Ratanji KD et al. Immunogenicity of therapeutic proteins: influence of aggregation. J Immunotoxicol 2014;11(2):99-109.